期刊
JOURNAL OF PHARMACOLOGICAL SCIENCES
卷 109, 期 4, 页码 583-592出版社
JAPANESE PHARMACOLOGICAL SOC
DOI: 10.1254/jphs.08299FP
关键词
manassantin A; dendritic cell; maturation; mitogen-activated protein kinase; NF-kappa B
资金
- Korea Government (MOST) [R13-2008-001-00000-00]
Manassantin A (MSA) inhibits nitric oxide production by macrophages through the inhibition of NF-kappa B activation, but the effect of MSA on dendritic cells has not been elucidated yet. Here we investigated the inhibitory effects of MSA on immune functions of dendritic cells (DCs). MSA inhibited lipopolysaccharide (LPS)-induced phenotypic Maturation of DCs, which was proved by the decreased expression of CD40, CD80, CD86, MHC-I, and MHC-II. MSA also inhibited functional maturation of DCs, that is, decreased the gene expression of IL-12, IL-1 beta, TNF-alpha, and IFN-alpha/beta; enhanced antigen Capture capacity of DCs; and impaired induction of allogenic T cell activation. As a mechanism of action, MSA inhibited LPS-induced activation of NF-kappa B, ERK, p38, and JNK, which played pivotal roles in toll-like receptor 4-mediated DC maturation. Collectively, these results suggested that MSA might be used for the treatment of DC-related immune diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据